RHI
43
15
DRI
61
-2
NWS
77
8
AIV
60
3
DAL
48
-2
ZTS
49
20
FIS
50
-3
CINF
48
-2
CSCO
53
2
HCA
55
2
CA
40
4
O
37
-2
BAX
41
3
MRK
66
3
VZ
25
-2
BRK.B
42
2
XYL
43
-4
HD
57
3
VMC
57
3
PRU
50
2
RHI
43
15
DRI
61
-2
NWS
77
8
AIV
60
3
DAL
48
-2
ZTS
49
20
FIS
50
-3
CINF
48
-2
CSCO
53
2
HCA
55
2
CA
40
4
O
37
-2
BAX
41
3
MRK
66
3
VZ
25
-2
BRK.B
42
2
XYL
43
-4
HD
57
3
VMC
57
3
PRU
50
2
Financhill
Back

Match Group Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
60

MTCH
Match Group

Last Price:
31.01
Seasonality Move:
-4.21%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Buy
60
Match Group (MTCH) is a Buy

Is Match Group a Buy, Sell or Hold?

  • The current Match Group [MTCH] share price is $31.01. The Score for MTCH is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • MTCH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MTCH Stock Price Chart

What is Match Group's stock price today?

  • The Match Group share price today is $31.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTCH is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

MTCH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 49.26 Sell
Chaikin Money Flow: 5131215 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.87 - 31.67) Buy
Bollinger Bands (100): (30.94 - 35.84) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

MTCH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.03 Sell
20-day SMA: 30.84 Buy
50-day SMA: 31.22 Sell
200-day SMA: 34.66 Sell
8-day EMA: 30.93 Buy
20-day EMA: 31.02 Sell
50-day EMA: 31.62 Sell
200-day EMA: 35.26 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Match Group Earnings Growth & MTCH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.39 per share, and an increase next year of $0.32 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Match Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):